Arrowhead Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ARWR and other ETFs, options, and stocks.

About ARWR

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC.

CEO

Christopher Richard Anzalone

CEOChristopher Richard Anzalone

Employees

609

Employees609

Headquarters

Pasadena, California

HeadquartersPasadena, California

Founded

1989

Founded1989

Employees

609

Employees609

ARWR Key Statistics

Market cap

2.31B

Market cap2.31B

Price-Earnings ratio

-13.68

Price-Earnings ratio-13.68

Dividend yield

—

Dividend yield—

Average volume

1.53M

Average volume1.53M

High today

$19.33

High today$19.33

Low today

$16.67

Low today$16.67

Open price

$19.05

Open price$19.05

Volume

3.01M

Volume3.01M

52 Week high

$29.86

52 Week high$29.86

52 Week low

$9.57

52 Week low$9.57

ARWR News

Simply Wall St 12h

Insiders At Arrowhead Pharmaceuticals Sold US$3.1m In Stock, Alluding To Potential Weakness

The fact that multiple Arrowhead Pharmaceuticals, Inc. ( ) insiders offloaded a considerable amount of shares over the past year could have raised some eyebrows...

Analyst ratings

67%

of 15 ratings

Buy

66.7%

Hold

33.3%

Sell

People also own

Based on the portfolios of people who own ARWR. This list is generated using Robinhood data, and it’s not a recommendation.